The pharmaceutical industry in the Philippines has been seeing stable growth for the past decade, and it looks set to continue. Though the market stood at $4.3bn in 2013, several recent and incoming changes could enable to sector to reach approximately $8bn by 2020. The increase is linked to the government’s intervention in price control and a...
Though health care sector spending is on the rise in the Philippines, years of underinvestment have resulted in a deficit in both available facilities and services. Although improvements are being made – in 2014 the Philippine government spending on health care reached the 5% of GDP recommended by the WHO – to reach the levels of care planned...
The Philippine experiment of combining public health care spending with private sector delivery continues to evolve. As health care remains central to the public interest, there is a heavy onus on improving access and efficiency in accordance with the goal of providing universal health care coverage for all Filipinos by 2016. The year 2015 is expected to focus on consolidation, as...
As demand for in-patient services continues to grow, to what extent is the sector’s expansion adequately addressing the need for additional services?
As is the case in many developing countries, the economic costs of substance abuse are increasing in Abu Dhabi. The financial burdens of lost productivity, incarceration, treatment and rehabilitation have led the emirate to move forward on an ambitious expansion of the government-owned National Rehabilitation Centre (NRC), which has already seen in-patient and outpatient...
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×